A team out of Texas A&M University is a finalist for Boeing's GoFly competition. Courtesy of GoFly

A team from Texas A&M University has advanced in a global Boeing-sponsored competition called GoFly. The competition asks teams to create a personal flying device aircraft that is smaller, lighter, and quieter than any currently existing model.

Texas A&M Harmony is one of the five teams named a winner in GoFly's Phase II competition, which has more than 3,500 innovators from 101 countries across the world. The teams are now preparing for the Final Fly-Off expected to take place in 2020, at which point innovators will put their aircrafts to the test, competing at a final event showcase and for the remaining $1.6 million in prizes.

Dr. Moble Benedict leads the team and is an assistant professor of aerospace engineering at TAMU and founder of the Advanced Vertical Flight Laboratory with 15 years of experience in vertical take-off and landing aircraft concepts. Texas A&M Harmony is the only team from Texas currently in the competition.

"The first time I heard about the GoFly competition, I thought 'this is impossible I can't do it,'" says Moble Benedict, Harmony's team captain and an assistant professor of aerospace engineering at TAMU.

Benedict, who also founded the Advanced Vertical Flight Laboratory with 15 years of experience in vertical take-off and landing aircraft concepts, proposed the competition to his students and his connections in the field to build his current team.

"The first few months we spent brainstorming different ideas," Benedict tells InnovationMap.

The team created a design called Aria, which was inspired by the word's musical roots.

"Being engineers, we were trying to stick with a theme," says Carl Runco, a PhD student at the Advanced Vertical Flight Lab of TAMU. "We struck on 'Aria,' and thought 'that's it' because Aria is the solo of an opera and we're designing a single-person vehicle."

Aria is a high technology readiness level compact rotorcraft designed to minimize noise and maximize efficiency, safety, reliability, and flight experience, according to the GoFly website.

"The key outcome of this design is the rotor system we have designed," says Benedict. "We have come up with a very unique rotor system which is very quiet without compromising the efficiency. That's something very hard to do."

In addition to Benedict and Runco, the Harmony team has a total of 12 members — from PhDs to professors, including:

  • David Coleman, a PhD student conducting research at AVFL (Advanced Vertical Flight Laboratory)
  • Hunter Denton, a Masters student in AVFL at TAMU
  • Dr. Eric Greenwood, who received a PhD in Aerospace Engineering from the University of Maryland and is a researcher at NASA Langley developing rotor noise modeling methods and experimental techniques
  • Atanu Halder, a PhD candidate in Aerospace Engineering at TAMU
  • Dr. Vikram Hrishikeshavan, an Assistant Research Scientist at the University of Maryland with 14 years of experience in VTOL aircraft concepts
  • Dr. Vinod Lakshminarayan, a Research Scientist at Science and Technology Corporation, NASA Ames Research Center
  • Bochan Lee, a South Korean Navy UH-60 pilot and a current graduate researcher at AVFL
  • Farid Saemi, a PhD student at TAMU
  • Vishaal Subramanian, a Masters student at the Aerospace department of TAMU
  • Aswathi Sudhir, a PhD student in Materials and Structures from Aerospace department of TAMU.

Winning the competition would put the Texas university on the map for aerospace engineering.

"The recognition would be invaluable," says Saemi.

The GoFly competition is broken up into three phases that began in 2017 according to the website. The first phase focused on written reports detailing each team's design and plan. After advancing through that round, Harmony entered Phase II, which included a re-review of Phase I materials and a demonstration of the progress each team has made. The five winners of Phase II will compete in a fly-off in 2020.

Other teams based in the United States include Trek Aerospace FK2 Inc. and DragonAir Aviation. International teams include Silverwing Personal Flight, from the Netherlands, and Aeroxo LV, from Latvia and Russia.

"We're inspired and excited to see the strong progress that GoFly competitors have made on their bold, creative designs," says Greg Hyslop, Boeing's CTO, in the press release. "Their work confirms a principle that's at the core of both Boeing and GoFly: aerospace innovation changes the world."

While the team is focused on next year's fly-off competition, they see the potential for a company taking off.

"If we're successful enough and attract enough attention, there is definitely interest in turning the team into an official company," says Runco. "We want to be able to sell these things."

Texas A&M Harmony has 12 team members and is advancing to the final round of the competition. Courtesy of GoFly

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Promising Houston sleep tech startup readies for big year of growth, work toward FDA clearance

HOUSTON INNOVATORS PODCAST EPISODE 268

There's a slew of treatment options for people living with sleep apnea. But, the bigger problem, as Meagan Pitcher realized during her time at the Texas Medical Center's Biodesign program, is that there's no easy way to reliably diagnose and determine a treatment plan for patients.

"We saw all of the companies trying to solve the problem of making the airway collapse less or make the air way wider — it might be surgery, might be medication, or nerve stimulation," Pitcher says on the Houston Innovators Podcast. "One of the things we found was that it was really hard to match a patient with sleep apnea with a good treatment for them. One of the reasons is it's hard to get an understanding of where the individual's site of collapse is as sleep medicine is currently practiced."

As Pitcher went through the TMC Biodesign program, she teamed up with her co-founders — CTO Onur Kilicand and CMO Britt Cross — to find a solution, and together they developed Bairitone Health. The company's technology provides at-home medical imaging using sonar sensing. The non-invasive device has the potential to replace the current standard of care, which is a surgical procedure.



This year, the company joined Activate Houston's inaugural cohort as the lone biotech company. Activate, which announced its expansion to Houston in 2023, helps hardtech founders develop and grow their companies from bench to commercialization, though it mostly focuses on industrial or climatetech innovators. In addition to this accomplishment, Bairitone Health was among the 2024 Houston Innovation Awards finalists.

While 2024 was successful for the company, next year should bring even more milestones for Bairitone, Pitcher says, including a seed round of funding that will support the growth of their team, fund early testing, and fuel Baritone's path toward FDA clearance.

"2025 is going to be a big year for Bairitone, especially around solidifying our regulatory plan. The device we're making is really low risk — we're not putting anything into the body, and we're potentially replacing a surgical procedure," Pitcher says. "We've always hypothesized that we'll have a 510(k) clearance with the FDA, but we're moving toward having our first meeting with the FDA to solidify those plans."

Bairitone's journey so far has been a uniquely Houston story, as Pitcher acknowledges.

"I really love Houston — especially for med tech. The medical center is just awesome, you have all these brilliant people coming in from the entire world to work at these institutions," Pitcher says. "It's kind of because of this atmosphere of excellence around health care, innovation, open mindedness, and collaboration — those are reasons why I really love working in Houston."

Top stories: Houston's most-read health tech news of 2024

year in review

Editor's note: As the year comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. In the health tech category on InnovationMap, top stories included startup funding raised, IPO plans, FDA clearance, and more. Be sure to click through to read the full story.

New report ranks Houston top market for life sciences

Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. Photo by Natalie Harms/InnovationMap

Thanks in large part to producing hundreds of college-trained professionals, Houston’s life sciences industry ranks among the top U.S. markets for talent in 2024.

In a report published by commercial real estate services company CBRE, Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. From 2017 to 2022, Houston notched a growth rate of 32.4 percent in this category.

In 2022, the University of Houston led the higher education pack in the region, graduating 746 people with a bachelor’s degree or above in biological or biomedical sciences, according to the report. Continue reading.

Houston innovator raises pre-seed funding for health care staffing platform

Ayoade Joy Ademuyewo founded Lokum last year to create a solution to better connecting medical specialists with health care facilities nationwide. Photo courtesy of Lokum

A Houston health care innovator is celebrating an oversubscribed round of pre-seed funding to improve on her startup's unique staffing platform.

Ayoade Joy Ademuyewo founded Lokum last year to create a solution to better connecting medical specialists with health care facilities nationwide. The new platform, which cuts out the middleman and lowers staffing costs, raised $700,000 in pre-seed funding that will go toward further development of the technology.

"Healthcare organizations spend $26 billion annually to support a crippling dependence on third-party agencies for connecting with clinical staff," Ademuyewo says in a news release. "Technological solutions that are pointed precisely to streamline and strengthen the relationships between highly specialized clinicians and their future employers are vital to alleviating this detrimental dependance, and central to our mission." Continue reading.

Houston regenerative medicine company to IPO, move toward more human trials

FibroBiologics will IPO this week. Photo via Getty Images

Want a piece of one of Houston’s most promising biotech companies? On January 31, FibroBiologics will begin the trading of its common stock on the Nasdaq stock exchange.

While most labs in the realm of regenerative medicine are focused on stem cells, FibroBiologics has bet on fibroblasts as the secret to treating myriad ailments. Fibroblasts, the most common type of cell in the body, are the primary cells that compose connective tissue.

Interested investors can find a prospectus to peruse before taking the leap. FibroBiologics filed with the U.S. Securities & Exchange Commission (SEC) on November 7, 2023. In September, FibroBiologics CEO Pete O’Heeron told InnovationMap, “I think what we're going to see is that fibroblasts are going to end up winning... They're just a better overall cell than the stem cells.” Continue reading.

Houston organizations identify promising life science cos. at annual event

The Rice Alliance and BioHouston acknowledged innovations from a dozen promising health tech companies. Photo via Rice University

For the 13th year, the Texas Life Science Forum hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship celebrated innovative companies from around the world that are creating new treatments and solutions to today's biggest health care challenges.

This week, over 40 companies presenting their innovations across cancer, cardiovascular disease, biotechnology, and more. Nearly 700 venture capitalists, corporate innovation groups, angel networks, industry leaders, academics, service providers, and others attended the event on November 7 at Rice's BioScience Research Collaborative in the Texas Medical Center.

Just like in previous years, the event ended with the announcement of the 10 companies that were deemed "most promising" based on their pitches and technologies. Of the 10 companies named, six are headquartered in Houston and an additional two startups on the list have a presence here. Continue reading.

FDA greenlights Houston surgery robotics company's unique technology

EndoQuest Robotics secured an Investigational Device Exemption from the FDA for its clinical study. Photo via Getty Images

A Houston surgical robotics company has gotten a Investigational Device Exemption from the FDA to go forward with human trials.

This news allows EndoQuest Robotics to begin its Prospective Assessment of a Robotic-Assisted Device in Gastrointestinal Medicine (PARADIGM) study, which will be conducted at leading United States health care facilities, including Brigham and Women’s Hospital (Boston), Mayo Clinic (Scottsdale), Cleveland Clinic (Cleveland), AdventHealth (Orlando), and HCA Healthcare (Houston). The study will include surgeries on 50 subjects, who will hopefully begin to enroll in January.

“The foundational thesis is we're trying to make sure that the world's largest medical center is also the world's largest med tech innovation center,” Eduardo Fonseca, interim CEO of EndoQuest Robotics, tells InnovationMap. Continue reading.

Houston billionaire Tilman Fertitta nominated as ambassador to Italy

foreign affairs

Houston billionaire and Rockets owner Tilman Fertitta has been nominated to serve as the United States ambassador to Italy, according to U.S. President-elect Donald Trump.

On Saturday, Trump sent the following statement via Truth Social Post:

"I am pleased to announce that Tilman J. Fertitta has been nominated to serve as the United States Ambassador to Italy. Tilman is an accomplished businessman, who has founded and built one of our Country's premier entertainment and real estate companies, employing approximately 50,000 Americans. Tilman has a long history of giving back to the community through numerous philanthropic initiatives, which include children's charities, Law Enforcement, and the medical community. Additionally, Tilman is the longest serving Chairman of the Board of Regents for the University of Houston. He also owns the Houston Rockets Basketball Team. Congratulations to Tilman, and his remarkable family!"

Fertitta, 67, also is the chairman, CEO, and president of Landry's Inc. and the chairman of the University of Houston's board of regents.

"It is an honor to be nominated to serve my country as ambassador to Italy and I look forward to the process ahead. Italy is such an extraordinary country with its wonderful people, culture, and history and its strategic importance to The United States of America," Fertitta said.

---

Read the full story on CultureMap's news partner, ABC13.com.